ID: ALA269349

Max Phase: Preclinical

Molecular Formula: C50H74N12O9

Molecular Weight: 987.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C1CCCCC1

Standard InChI:  InChI=1S/C50H74N12O9/c1-29(2)19-36(42(64)24-43(65)57-38(20-30(3)4)46(67)59-37(45(51)66)21-32-13-8-6-9-14-32)58-47(68)39(22-34-25-52-27-54-34)60-49(70)44(33-15-10-7-11-16-33)61-48(69)41-17-12-18-62(41)50(71)40(56-31(5)63)23-35-26-53-28-55-35/h6,8-9,13-14,25-30,33,36-42,44,64H,7,10-12,15-24H2,1-5H3,(H2,51,66)(H,52,54)(H,53,55)(H,56,63)(H,57,65)(H,58,68)(H,59,67)(H,60,70)(H,61,69)/t36-,37-,38-,39-,40-,41+,42-,44-/m0/s1

Standard InChI Key:  FKDAFTKTOYPFII-KMVXVDKCSA-N

Associated Targets(non-human)

Renin 163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 987.22Molecular Weight (Monoisotopic): 986.5702AlogP: 0.99#Rotatable Bonds: 26
Polar Surface Area: 315.59Molecular Species: NEUTRALHBA: 11HBD: 10
#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.61CX Basic pKa: 6.84CX LogP: 0.00CX LogD: -0.10
Aromatic Rings: 3Heavy Atoms: 71QED Weighted: 0.05Np Likeness Score: -0.01

References

1. Hui KY, Holtzman EJ, Quinones MA, Hollenberg NK, Haber E..  (1988)  Design of rat renin inhibitory peptides.,  31  (9): [PMID:3045320] [10.1021/jm00117a003]

Source